FAUSTINO HERNANDEZ HERNANDEZ: Open Payments
NPI 1831555457 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,417 in 82 payments from 11 companies in 2025. Trend: 2023 $372 · 2024 $1,276 · 2025 $1,417
Food & beverage: $1,317Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 34 | $582 |
| Galderma Laboratories, L.P. | 8 | $275 |
| Arcutis Biotherapeutics, Inc. | 20 | $168 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $89 |
| ABBVIE INC. | 3 | $81 |
| UCB, Inc. | 3 | $77 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| PFIZER INC. | 2 | $40 |
| Lilly USA, LLC | 1 | $23 |
| GENZYME CORPORATION | 1 | $15 |
Products named: TREMFYA, NEMLUVIO, Zoryve, ILUMYA, Bimzelx, SKYRIZI, CIBINQO, COSENTYX.
Industry payments across FL — which companies pay providers there.
